Foreword - 2018 Issue 5
Professor Allan H. Young
CEPiP.2018.1.iii |
Editorial - 2018 Issue 5
Rashid Zaman, Mark Agius and Frank M. C. Besag
CEPiP.2018.1.iv-v |
Depression, historical aspects
Rashid Zaman
CEPiP.2018.1.1-4 |
The epidemiology of major depressive disorder: consequences for society and for the individual
Anna Mckeever, Mark Agius and Pavel Mohr
CEPiP.2018.1.5-19 |
Genetics, epigenetics and BDNF in depression
Jurij Bon, Peter Pregelj and Alija Videtic Paska
CEPiP.2018.1.20-25 |
Role of inflammation and immunity in depression
Golam M. Khandaker and Edward T. Bullmore
CEPiP.2018.1.26-31 |
Stress, cortisol and depression
Helen Patricia Gaete and Rashid Zaman
CEPiP.2018.1.32-36 |
Neuroimaging findings in depression
Thomas Frodl and Leonardo Tozzi
CEPiP.2018.1.37-41 |
Cognitive dysfunction in depression: an unmet clinical need
Muzaffer Kaser, Rashid Zaman and Barbara J. Sahakian
CEPiP.2018.1.42-46 |
Do antidepressants affect neurogenesis and how does neurogenesis relate to depression?
Ada Maria Krzak, Jenny Jia Ling Cao, Mark Agius and Cyril Hoschl
CEPiP.2018.1.47-54 |
Antidepressants in clinical practice
Mark Agius and Hanna Bonnici
CEPiP.2018.1.55-63 |
Psychosocial factors in the aetiology of unipolar depression
Mina Ibrahimi, Lucia Coulter, Ravi Patel and Mark Agius
CEPiP.2018.1.64-69 |
Using the PHQ-9 self-rating scale to assess depression in primary care
Ankita Sahni and Mark Agius
CEPiP.2018.1.70-75 |
Can the two questions of the PHQ-2 screen effectively for depression?
Rachel Wilson and Mark Agius
CEPiP.2018.1.76-80 |
Assessing depression and suicidality in the A&E department
Bruno de Blaquiere, Sophie Butler, Mark Agius and Isabel McMullen
CEPiP.2018.1.81-87 |
Suicide, homicide and infanticide in depression
Karyn Ayre and Rina Dutta
CEPiP.2018.1.88-92 |
Management of adults with depression in primary care
Carolyn Chew-Graham and Daniel Dietch
CEPiP.2018.1.93-100 |
How long should an episode of depression be treated for and at what dose of antidepressants?
Andre Tylee and Jeremy Broadhead
CEPiP.2018.1.101-104 |
Collaborative care for depression
Carolyn Chew-Graham
CEPiP.2018.1.105-109 |
Training initiatives for GPs on depression in which suicide rate reduction is the main outcome measure
Xenia Gonda, Annamaria Rihmer, Peter Dome and Zoltan Rihmer
CEPiP.2018.1.110-114 |
What evidence is there that general practitioners follow guidelines on the use of antidepressants to treat depression, and how can this be improved?
Shentong Wang, Katherine Alice Wilkinson and Mark Agius
CEPiP.2018.1.115-119 |
Managing treatment resistant depression: what do the guidelines say?
Maria Antonietta Nettis and Carmine M. Pariante
CEPiP.2018.1.120-125 |
Treatment-resistant depression: when should we consider bipolarity?
Nefize Yalin MD and Allan H. Young
CEPiP.2018.1.126-129 |
The role of ECT in depression
Ellen Hartland and Vimal Sivasanker
CEPiP.2018.1.130-135 |
Cognitive behaviour therapy for adults with depression: an overview of practical application
John Butler
CEPiP.2018.1.136-145 |
Psychodynamic psychotherapy for depression
Ivan Urlic
CEPiP.2018.1.146-155 |
Depression: how can NGOs help?
Amelia Mustapha
CEPiP.2018.1.156-158 |
Suffering depression in the Christian Church - one person's experience
Katharine Welby-Roberts
CEPiP.2018.1.159-162 |
Identification and treatment of postnatal depression in primary care
Ethel Felice, Rachel Buhagiar and Anton Grech
CEPiP.2018.1.163-168 |
Depression in children and adolescents. A commentary on the NICE guidance
Francesca Falzon Aquilina, Norma Verdolini, Mark Agius and Zoltan Rihmer
CEPiP.2018.1.169-180 |
Depression in older adults: how do the symptoms differ from adult depression?
Janitha L. Jayasinghe and Nadeem Mazi-Kotwal
CEPiP.2018.1.181-189 |
Depression, cardiovascular disease and stroke
Stephanie Anne Ewen and Isabel McMullen
CEPiP.2018.1.190-196 |
Depression in diabetes
Calum D. Moulton and Khalida Ismail
CEPiP.2018.1.197-202 |
Depression and epilepsy
Frank M. C. Besag and Michael Vasey
CEPiP.2018.1.203-215 |
Depression in neurological disorders: Parkinson disease and multiple sclerosis
Francesca Falzon Aquilina and Mark Agius
CEPiP.2018.1.216-221 |
Depression and substance abuse
Anton Grech and Daniel Vella Fondacaro
CEPiP.2018.1.222-225 |
Culture and depression
Amanda Birkstock, Ahmed Hankir, Dinesh Bhugra and Rashid Zaman
CEPiP.2018.1.226-229 |
Neurostimulation techniques in the treatment of depression
Jorge Ransfield and Rashid Zaman
CEPiP.2018.1.230-234 |
Ketamine in the treatment of depression: opportunities and risks
James M. Stone
CEPiP.2018.1.235-238 |
e-Mental health in the management of depression
Davor Mucic
CEPiP.2018.1.239-242 |
Overview: a brief summary of current and future treatments for depression
Rashid Zaman
CEPiP.2018.1.243-244 |
